Business Context and Reporting Period
Company: Smith & Nephew plc (LSE: SN, NYSE: SNN)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date of Filing: October 16, 2024
Reporting Period: This filing serves as a timing announcement for the Third Quarter 2024 trading report, covering the period ended September 28, 2024. The actual financial results are scheduled for release on October 31, 2024.
Business Overview: A global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company operates three global business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It employs approximately 18,000 people across more than 100 countries.
Key Financial Metrics
Current Period Data: The filing text does not provide specific financial values (revenue, profit, cash flow, margins, debt, or liquidity) for the third quarter of 2024. This document is a notice of the upcoming announcement rather than the results themselves.
Historical Context: The company generated annual sales of $5.5 billion in 2023.
Material Changes
The filing does not contain data regarding material changes versus the prior comparable period, as the third-quarter 2024 financial results have not yet been disclosed.
Guidance, Outlook, and Risks
Outlook and Guidance: The document contains forward-looking statements regarding expected revenue growth and trading profit margins but does not provide specific numerical guidance in this filing.
Management Commentary: Management emphasizes the company's purpose, "Life Unlimited," and its focus on restoring patients' lives through technology.
Risks and Contingencies: The filing lists numerous factors that could cause actual results to differ from expectations, including:
- Conflicts in Europe and the Middle East.
- Economic and financial conditions affecting healthcare providers and payers.
- Price levels for medical devices and reimbursement decisions.
- Regulatory approvals, product defects, recalls, or quality management failures.
- Litigation, patent claims, and legal compliance risks.
- Supply chain disruptions and competition for personnel.
- Cybersecurity threats and reliance on information technology.
- Natural disasters, climate change, and foreign exchange volatility.
Investor Verification Checklist
- Verify the release of the Third Quarter 2024 trading report on October 31, 2024, at 7:00 am GMT.
- Confirm attendance or access to the conference call for financial analysts scheduled for 8:30 am GMT on October 31, 2024.
- Review the company's website (smith-nephew.com) for the official presentation and detailed financial tables once released.
- Monitor for any updates regarding the specific risks listed, particularly geopolitical conflicts and supply chain disruptions, which may impact the upcoming quarter's performance.